Exceptions were a 19 % and a 22 % reduction in warfarin C max when administered with lixisenatide or dulaglutide (both doses of 1.5 mg and 4.5 mg), respectively [15, 31, 32] that were not considered to be of clinical importance
These additional benefits include: Lower blood pressure Better breathing Increased kidney function Improved mobility and joint health in general Better overall hormonal balance Increased energy levels Increased body image and confidence due to weight loss May help sleep-related issues Lowers cardiometabolic risks in obese patients May improve circulation May decrease low back pain, knee related discomforts and strain on joints, bones and cartilage Could help lower cholesterol levels Who Can Take These Weight Loss Injections Along with Some Precautions
The Food and Drug Administration has approved both substances as drugs
Francesco Puppi, recent podium finisher of the Western States 100, wrote a thoughtful piece about the state of drug testing in ultras following the high profile test failure of Joyline Chepngeno in 2025
Ultrasound in Obstetrics & Gynecology , 42(4), 434-439
10.1016/j.ab.2021.114330 7